News
Findings from the TRAILBLAZER-ALZ 2 long-term extension study highlight Kisunla (donanemab-azbt) continued to demonstrate ...
Zacks Investment Research on MSN6h
Should You Buy, Sell or Hold Lilly Stock Ahead of Q2 Earnings?Eli Lilly and Company LLY will report its second-quarter earnings on Aug. 7, before market open. The Zacks Consensus Estimate ...
The US Food and Drug Administration (FDA) has approved a label update for Swiss pharma giant Novartis’ Leqvio (inclisiran), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback